Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery

NCT01825720 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Valvular Heart Disease

Interventions

DRUG: (Glucose-Insulin-Potassium)GIK group
DRUG: normal saline group

Sponsor

Yonsei University